Regional BioCamp 2012
May 20 - 22, 2012, Ljubljana, Slovenia
The Regional BioCamp 2012 is a three day forum, that brings together selected top students with distinguished experts and top managers. It is a great opportunity to gain direct insight into the world of research and international business environment within the pharmaceutical industry.
The best students at the Regional BioCamp Alpe-Adria awarded
23. 5. 2012 | At the conclusion of the Regional BioCamp 2012, the winners of the competition part were announced. As a part of the event, which has been organized for the second time by Lek, a Sandoz Company, for promising science students from the Alpe-Adria region, Daliborka Dušanič from Biotechnical Faculty, Ljubljana and Miha Kosmač, a post-doctorial biomedicine researcher at the University of Ljubljana, developed the best case study … more »
Second Regional BioCamp dedicated to contemporary approaches in treatment of cancer and neglected diseases
21. 5. 2012 | From 20–22 May 2012, the Regional BioCamp is once again hosting in Ljubljana 35 selected best and most promising undergraduate and postgraduate natural-science students from the Alpe–Adria region … more »
Program
- Key-note presentations of leading scientists from academia, Sandoz and Novartis:
- New developments in generic pharmaceutical industry
- Innovative approach in developing contemporary medication
- Biosimilars in oncology
- Starting a biotechnology company
- Patients as partners in cancer medication
- Career opportunities in pharmaceutical industry
- Students’ workshop:
- How to develop and launch a pharmaceutical product
- A visit to Sandoz development facilities in Slovenia
Sunday, 20 May
- Ljubljana sightseeing and welcome dinner in Ljubljana city centre
Monday, 21 May: Contemporary Approaches in Cancer Diagnostics and Therapy
- Welcome address by Vojmir Urlep, President of the Lek Board of Management
- Key note presentations by:
- Prof. Dr. Uroš Urleb, Chief Scientific Officer, Sandoz
- Dr. Anandhi Johri, Head Global Program Oncology Development, Sandoz/Novartis
- Prof. Dr. Boris Turk, Head of Department Biochemistry & Molecular & Structural Biology at Institute »Jožef Stefan«, Prof. at Faculty of Chemistry and Chemical Technology
- Prof. Dr. Paul Herrling, Chairman, Novartis Institute for Tropical Diseases, Novartis
- Dr. Simona Borštnar, Division of Medical Oncology, Institute of Oncology Ljubljana
- Dr. Mojca Senčar, President, EuropaDonna
- Dr. Klemen Španinger, Director, Diagenomi d.o.o.
- Case study introduction and work in break-out sessions
Tuesday, 22 May
- Case study finalization in break-out sessions
- Visit to one of Sandoz develeopmnet centers in Slovenia and Lavička collection
- Case study team presentations
- Key note presentation:
- Samo Roš, Head of Human Resources and member of the Lek Board of Management and Dr. Violeta Gabrijelčič, Global Head Pharmaceuticals and Device Development, Global Biopharmaceutical Development, Sandoz
Participating countries
- Slovenia
- Croatia
- Bosnia and Herzegovina
- Serbia
- Macedonia
- Austria (Graz)
- Italy (Trieste)